Biotechnology – Page 6

Eli Lilly Expands Global Innovation Reach with New Research Centers in China

10 months ago talkbio0Tagged Biotechnology, China, Drug Development, Eli, Eli Lilly, Gateway, innovation, Research Organization

Eli Lilly, China, Research Centers, Innovation, Gateway Labs, Biotechnology, Drug Development

Pfizer and Triana Biomedicines Collaborate on Molecular Glue Discovery for Cancer and Other Diseases in $1.5 Billion Deal

10 months ago talkbio0Tagged Biotechnology, Drug Discovery, molecular glue, Neoplasms, Pfizer, Triana Biomedicines

Pfizer, Triana Biomedicines, molecular glue, cancer, oncology, drug discovery, biotechnology, pharmaceuticals

Upstream Bio Expands IPO to $255 Million, Set to Join Nasdaq Alongside CAMP4

11 months ago talkbio0Tagged allergic diseases, Biotechnology, CAMP4, Inflammatory disorder, IPO, Nasdaq, Upstream Bio

Upstream Bio, IPO, Nasdaq, CAMP4, Biotechnology, Inflammatory Diseases, Allergic Diseases

Basecamp Research Secures $60M to Revolutionize AI Drug Discovery with Broad Institute Partnership

11 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial (qualifier value), biology (field), Biotechnology, Broad Institute, gene therapy, IMMUNODEFICIENCY, COMMON VARIABLE, 10, R. Liu, research

AI drug discovery, Basecamp Research, Broad Institute, David R. Liu, Biotechnology, Gene therapy, Artificial intelligence in biology

Eli Lilly and insitro Collaborate on AI-Driven Metabolic Disease Therapies

11 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Biotechnology, Drug Discovery, Eli, Eli Lilly, GalNAc, Insitro, Metabolic Diseases, pharmaceutical partnership, RNA, Small Interfering

Eli Lilly, insitro, AI, metabolic diseases, siRNA, GalNAc, drug discovery, biotechnology, pharmaceutical partnership

BIOSECURE Act: A Potential Game-Changer for Biopharma – Industry Implications and Future Directions

11 months ago talkbio0Tagged Biopharma Industry, BIOSECURE, Biotechnology, regulatory, Relations, Supply chain diversification, U.S., U.S.-China

BIOSECURE Act, Biopharma industry, US-China relations, Biotechnology collaborations, Supply chain diversification, Regulatory compliance

BIOSECURE Act: Navigating Industry Implications and Future Directions

11 months ago talkbio0Tagged BIOSECURE, Biotechnology, capabilities, CDMOs, Chinese Language, Contract agreement, development aspects, Industry, Manufacture, manufacturing organizations, pharmaceutical imports, Pharmaceutical supply chain resilience, Supply chain disruptions, United States

BIOSECURE Act, Biotechnology industry, Supply chain disruptions, Chinese pharmaceutical imports, U.S. manufacturing capabilities, Contract development and manufacturing organizations (CDMOs), Pharmaceutical supply chain resilience

Frazier Replenishes Fund with $630 Million for Public Biotech Investments

11 months ago talkbio0Tagged biotech fund, Biotechnology, Frazier, Investments, public biotechs

Frazier, biotech fund, public biotechs, investment, biotechnology

Septerna Embarks on IPO Journey with Promising Preclinical Data and Vision to Revolutionize GPCR Drug Discovery

11 months ago talkbio0Tagged agonists, Biotechnology, Drug Discovery, G-Protein-Coupled Receptors, Hypoparathyroidism, IPO, Preclinical, PTH1R gene, Septerna

Septerna, IPO, GPCR, preclinical data, drug discovery, biotechnology, PTH1R agonists, hypoparathyroidism

Frazier Life Sciences Boosts Evergreen Fund with $630M for Small and Mid-Cap Biotechs

11 months ago talkbio0Tagged Biotechnology, biotechs, Evergreen Fund, Frazier Life Sciences, Health care facility, Mid-Cap, Small

Frazier Life Sciences, Evergreen Fund, Small and Mid-Cap Biotechs, Healthcare Investment, Biotechnology Funding